BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age

Update Il y a 4 ans
Reference: EUCTR2014-000464-17

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the safety and efficacy of BOTOX for the treatment of urinary incontinence due to OAB in patients 12 to 17 years of age who have not been adequately managed with anticholinergic therapy. To evaluate the safety and efficacy of repeated BOTOX treatments in this patient population.


Inclusion criteria

  • Urinary Incontinence Due to Overactive Bladder